Search research articles
Contact Us
Filters
Showing results (11-20 of 43) with videos related to
Page
of 5
Sort By:
Medical Oncology (Northwood, London, England)
|
August 20, 2005
Liver resection after irinotecan, 5-fluorouracil, and folinic acid for patients with unresectable colorectal liver metastases: a multicenter phase II study by the Cancer Therapeutic Research Group
Wing M Ho, B Ma, Tony Mok, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))
|
November 23, 2007
A split-organ delineation approach for dose optimisation for intensity-modulated radiotherapy for advanced T-stage nasopharyngeal carcinoma
R M C Chau, S F Leung, M K M Kam, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 6, 2017
Identifying an early indicator of drug efficacy in patients with metastatic colorectal cancer-a prospective evaluation of circulating tumor cells, 18F-fluorodeoxyglucose positron-emission tomography and the RECIST criteria
B Ma, A D King, L Leung, et al.
Journal of Virology
|
October 15, 2003
HLA-A11-restricted epitope polymorphism among Epstein-Barr virus strains in the highly HLA-A11-positive Chinese population: incidence and immunogenicity of variant epitope sequences
R S Midgley, A I Bell, Q Y Yao, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))
|
November 21, 2018
The Use of Post-ablation Stimulated Thyroglobulin in Predicting Clinical Outcomes in Differentiated Thyroid Carcinoma - What Cut-off Values Should We Use?
K C W Wong, T Y Ng, K S Yu, et al.
The British Journal of Radiology
|
March 18, 2008
The impact of 18F-FDG PET/CT on assessment of nasopharyngeal carcinoma at diagnosis
A D King, B B Ma, Y Y Yau, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 15, 2011
Hemorrhagic complications in a phase II study of sunitinib in patients of nasopharyngeal carcinoma who has previously received high-dose radiation
E P Hui, B B Y Ma, A D King, et al.
Histopathology
|
July 31, 2002
Expression of epidermal growth factor receptor in head and neck cancers correlates with clinical progression: a multicentre immunohistochemical study in the Asia-Pacific region
T C Putti, K F To, H C Hsu, et al.
British Journal of Cancer
|
January 22, 2009
DLEC1 is a functional 3p22.3 tumour suppressor silenced by promoter CpG methylation in colon and gastric cancers
J Ying, F F Poon, J Yu, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 28, 2011
A phase II study of concurrent cetuximab-cisplatin and intensity-modulated radiotherapy in locoregionally advanced nasopharyngeal carcinoma
B B Y Ma, M K M Kam, S F Leung, et al.
Page
of 5
Search research articles
Search
Showing results (11-20 of 43) with videos related to
Sort By:
Page
of 5
Medical Oncology (Northwood, London, England)
|
August 20, 2005
Liver resection after irinotecan, 5-fluorouracil, and folinic acid for patients with unresectable colorectal liver metastases: a multicenter phase II study by the Cancer Therapeutic Research Group
Wing M Ho, B Ma, Tony Mok, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))
|
November 23, 2007
A split-organ delineation approach for dose optimisation for intensity-modulated radiotherapy for advanced T-stage nasopharyngeal carcinoma
R M C Chau, S F Leung, M K M Kam, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 6, 2017
Identifying an early indicator of drug efficacy in patients with metastatic colorectal cancer-a prospective evaluation of circulating tumor cells, 18F-fluorodeoxyglucose positron-emission tomography and the RECIST criteria
B Ma, A D King, L Leung, et al.
Journal of Virology
|
October 15, 2003
HLA-A11-restricted epitope polymorphism among Epstein-Barr virus strains in the highly HLA-A11-positive Chinese population: incidence and immunogenicity of variant epitope sequences
R S Midgley, A I Bell, Q Y Yao, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))
|
November 21, 2018
The Use of Post-ablation Stimulated Thyroglobulin in Predicting Clinical Outcomes in Differentiated Thyroid Carcinoma - What Cut-off Values Should We Use?
K C W Wong, T Y Ng, K S Yu, et al.
The British Journal of Radiology
|
March 18, 2008
The impact of 18F-FDG PET/CT on assessment of nasopharyngeal carcinoma at diagnosis
A D King, B B Ma, Y Y Yau, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 15, 2011
Hemorrhagic complications in a phase II study of sunitinib in patients of nasopharyngeal carcinoma who has previously received high-dose radiation
E P Hui, B B Y Ma, A D King, et al.
Histopathology
|
July 31, 2002
Expression of epidermal growth factor receptor in head and neck cancers correlates with clinical progression: a multicentre immunohistochemical study in the Asia-Pacific region
T C Putti, K F To, H C Hsu, et al.
British Journal of Cancer
|
January 22, 2009
DLEC1 is a functional 3p22.3 tumour suppressor silenced by promoter CpG methylation in colon and gastric cancers
J Ying, F F Poon, J Yu, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 28, 2011
A phase II study of concurrent cetuximab-cisplatin and intensity-modulated radiotherapy in locoregionally advanced nasopharyngeal carcinoma
B B Y Ma, M K M Kam, S F Leung, et al.
Page
of 5